Cipla Ltd. reported a weak performance for the Q4FY26, with consolidated net profit falling sharply on a year-on-year basis. The company’s board also recommended a final dividend of Rs 13 per equity share for the financial year ended March 31, 2026. The record date for the purpose of payment of final dividend, if declared has been set June 5, 2026.
The pharma major posted a consolidated net profit of Rs 555 crore for Q4FY26, below the estimated Rs 716 crore. On a year-on-year basis, profit was down 54.6% from Rs 1,222 crore reported in the same quarter last year.
Revenue from operations stood at Rs 6,541.2 crore, also missing the estimate of Rs 6,701 crore. Revenue was down 2.8% compared with Rs 6,730 crore in the corresponding quarter of the previous financial year.
The consolidated Ebitda stood at Rs 955 crore, against an estimated Rs 1,106 crore which means a 37.9% decline from Rs 1,538 crore reported in Q4FY25.
ALSO READ: Cipla Q4 Results: An All-Around Miss As Profit Tanks 54%
Cipla Q4FY26 (Cons)
Cipla Q4FY26 (Cons, YoY)
- Net Profit down 54.6% at Rs 555 crore versus Rs 1,222 crore
- Revenue down 2.8% at Rs 6,541 crore versus Rs 6,730 crore
- EBITDA down 37.9% at Rs 955 crore versus Rs 1,538 crore
Essential Business Intelligence,
Continuous LIVE TV,
Sharp Market Insights,
Practical Personal Finance Advice and
Latest Stories — On NDTV Profit.
